The latest government guidelines for diabetes screening missed 55 percent of high-risk individuals with prediabetes or diabetes, a new Northwestern Medicine study found.
Northwestern Medicine physicians participated in a clinical trial to investigate the safety and efficacy of a drug for weight management in overweight or obese adults with type 2 diabetes.